{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:02:02Z","timestamp":1771012922363,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1038\/sj.bjc.6600486","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T17:31:23Z","timestamp":1031074283000},"page":"385-392","source":"Crossref","is-referenced-by-count":46,"title":["Concurrent administration of Docetaxel and Stealth\u00ae liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection"],"prefix":"10.1038","volume":"87","author":[{"given":"M I","family":"Koukourakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Romanidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Froudarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Kyrgias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G V","family":"Koukourakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Retalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Bahlitzanakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,8,6]]},"reference":[{"key":"BF6600486_CR1","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0360-3016(01)01713-8","volume":"51","author":"D Antonadou","year":"2001","unstructured":"Antonadou D, Coliarakis N, Synodinou M, Athanassiou H, Kouveli A, Verigos C, Georgakopoulos G, Panoussaki K, Karageorgis P, Throuvalas N (2001) Randomized phase III trial of radiation treatment +\/\u2212 amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys 51: 915\u2013922","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6600486_CR2","unstructured":"Beham M, Vogel M, McDonnell TJ, Farkas ST, Furst A, Jauch KW (1998) Apoptosis after genotoxic damage is enhanced by Taxol induced phosphorylation of bcl-2 and correlates with nuclear import of p53. Proc Am Assoc Cancer Res 39: 463, AB 3151"},{"key":"BF6600486_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/09553009014550341","volume":"57","author":"JA Bonner","year":"1990","unstructured":"Bonner JA, Lawrence TS (1990) Doxorubicin decreases the repair of radiation-induced DNA damage. Int J Radiat Biol 57: 55\u201364","journal-title":"Int J Radiat Biol"},{"key":"BF6600486_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1200\/JCO.2001.19.3.792","volume":"19","author":"A Eisbruch","year":"2001","unstructured":"Eisbruch A, Schewach DS, Bradford CR, Littles JF, Teknos TN, Chepeha DB, Marentette LJ, Terrell JE, Hogikyan ND, Dawson LA, Urba S, Wolf GT, Lawrence TS (2001) Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. J Clin Oncol 19: 792\u2013799","journal-title":"J Clin Oncol"},{"key":"BF6600486_CR5","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","volume":"17","author":"K Furuse","year":"1999","unstructured":"Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, Katagami N, Ariyoshi Y (1999) Phase III study of concurrent versus sequential thoracic radiotherapy incombination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17: 2692\u20132699","journal-title":"J Clin Oncol"},{"key":"BF6600486_CR6","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/S0360-3016(96)00367-7","volume":"36","author":"MV Graham","year":"1996","unstructured":"Graham MV, Jahanzeb M, Dresler CM, Cooper JD, Emami B, Mortimer JT (1996) Results of a trial with topotecan dose escalation and concurrent thoracic radiation therapy for locally advanced, inoperable nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 36: 1215\u20131220","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6600486_CR7","first-page":"1253","volume":"56","author":"S Haldar","year":"1996","unstructured":"Haldar S, Chintapalli J, Croce CM (1996) Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56: 1253\u20131255","journal-title":"Cancer Res"},{"issue":"12","key":"BF6600486_CR8","first-page":"4939","volume":"6","author":"KJ Harrington","year":"2000","unstructured":"Harrington KJ, Rowlinson-Busza G, Syrigos KN, Vile RG, Uster PS, Peters AM, Stewart JS (2000) Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model. Clin Cancer Res 6: 12 4939\u20134949","journal-title":"Clin Cancer Res"},{"issue":"2","key":"BF6600486_CR9","first-page":"243","volume":"7","author":"KJ Harrington","year":"2001","unstructured":"Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG, Stewart JS (2001a) Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 7: 2 243\u2013254","journal-title":"Clin Cancer Res"},{"issue":"3","key":"BF6600486_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0360-3016(01)01508-5","volume":"50","author":"KJ Harrington","year":"2001","unstructured":"Harrington KJ, Rowlinson-Busza G, Syrigos KN, Uster PS, Vile RG, Peters AM, Stewart JS (2001b) The effect of irradiation on the biodistribution of radiolabeled pegylated liposomes. Int J Radiat Oncol Biol Phys 50: 3 809\u2013820","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"BF6600486_CR11","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S0360-3016(00)01444-9","volume":"49","author":"KJ Harrington","year":"2001","unstructured":"Harrington KJ, Rowlinson-Busza G, Uster PS, Vile RG, Peters AM, Stewart JS (2001c) Single-fraction irradiation has no effect on uptake of radiolabeled pegylated liposomes in a tumor xenograft model. Int J Radiat Oncol Biol Phys 49: 4 1141\u20131148","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6600486_CR12","first-page":"1842","volume":"56","author":"C Hennequin","year":"1996","unstructured":"Hennequin C, Giocanti N, Favaudon V (1996) Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells. Cancer Res 56: 1842\u20131850","journal-title":"Cancer Res"},{"key":"BF6600486_CR13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1200\/JCO.1996.14.4.1065","volume":"14","author":"B Jeremic","year":"1996","unstructured":"Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S (1996) Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin\/etoposide for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol 14: 1065\u20131070","journal-title":"J Clin Oncol"},{"key":"BF6600486_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/1097-0142(19870115)59:2<355::AID-CNCR2820590232>3.0.CO;2-E","volume":"59","author":"K Kayser","year":"1987","unstructured":"Kayser K, Bultzebruch H, Probsts G, Vogt-Moykopf I (1987) Retrospective and prospective tumor staging evaluating prognostic factors in operable bronchus carcinoma patients. Cancer 59: 355\u2013361","journal-title":"Cancer"},{"key":"BF6600486_CR15","first-page":"325a","volume":"20","author":"R Komaki","year":"2001","unstructured":"Komaki R, Lee JS, Kaplan B, Allen P, Kelly JF, Liao Z, Stevens CW, Fossella FV, Zinner RG, Papadimitrakopoulou V (2001) Randomized phase III study of chemoradiation\u00b1amifostine in patients with inoperable stage II-III non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 20: 325a abstract 1298","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6600486_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0360-3016(95)02102-7","volume":"34","author":"M Koukourakis","year":"1996","unstructured":"Koukourakis M, Hlouverakis G, Kosma L, Skarlatos J, Damilakis J, Giatromanolaki A, Yannakakis D (1996) The impact of overall treatment time on the results of radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 34: 315\u2013322","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6600486_CR17","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0959-8049(97)10101-0","volume":"34","author":"M Koukourakis","year":"1998","unstructured":"Koukourakis M, Kourousis C, Kamilaki M, Koukouraki S, Giatromanolaki A, Kakolyris S, Kotsakis A, Androulakis N, Bahlitzanakis N, Georgoulias V (1998a) Weekly Docetaxel and Concomitant Boost Radiotherapy for Non-Small-Cell Lung Cancer. A Phase I\/II Dose Escalation Trial. Eur J Cancer 34: 838\u2013844","journal-title":"Eur J Cancer"},{"key":"BF6600486_CR18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/00000421-199812000-00013","volume":"21","author":"M Koukourakis","year":"1998","unstructured":"Koukourakis M, Stefanaki E, Giatromanolaki A, Frangiadaki C, Armenaki A, Georgoulias V, Koumandakis E, Kranidis A, Helidonis E (1998b) Fractionated carboplatin radiosensitization. A phase I dose escalation study. Am J Clin Oncol 21: 595\u2013601","journal-title":"Am J Clin Oncol"},{"key":"BF6600486_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0360-3016(98)00370-8","volume":"43","author":"MI Koukourakis","year":"1999","unstructured":"Koukourakis MI, Giatromanolaki A, Schiza S, Kakolyris S, Georgoulias V (1999a) Concurrent twice-a-week docetaxel and radiotherapy. A dose escalation trial with immunological toxicity evaluation. Int J Radiat Oncol Biol Phys 43: 107\u2013114","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6600486_CR20","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1200\/JCO.1999.17.11.3512","volume":"17","author":"MI Koukourakis","year":"1999","unstructured":"Koukourakis MI, Koukouraki S, Giatromanolaki A, Archimandritis SC, Skarlatos J, Beroukas K, Bizakis JG, Retalis G, Karkavitsas N, Helidonis ES (1999b) Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatement of locally advanced non-small cell lung cancer and head and neck cancer. J Clin Oncol 17: 3512\u20133521","journal-title":"J Clin Oncol"},{"key":"BF6600486_CR21","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1038\/sj.bjc.6690599","volume":"80","author":"MI Koukourakis","year":"1999","unstructured":"Koukourakis MI, Bahlitzanakis N, Froudarakis M, Giatromanolaki A, Georgoulias V, Koumiotaki S, Christodoulou M, Kyrias G, Skarlatos J, Kostantelos J, Beroukas K (1999c) Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small cell lung carcinoma. Br J Cancer 80: 1792\u20131796","journal-title":"Br J Cancer"},{"key":"BF6600486_CR22","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1200\/JCO.2000.18.11.2226","volume":"18","author":"MI Koukourakis","year":"2000","unstructured":"Koukourakis MI, Kyrias G, Kakolyris S, Kouroussis C, Frangiadaki C, Giatromanolaki A, Retalis G, Georgoulias V (2000a) Subcutaneous Administration of Amifostine during Fractionated Radiotherapy: A randomized phase II study. J Clin Oncol 18: 2226\u20132233","journal-title":"J Clin Oncol"},{"key":"BF6600486_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/028418600430789","volume":"39","author":"MI Koukourakis","year":"2000","unstructured":"Koukourakis MI, Koukouraki S, Giatromanolaki A, Kakolyris S, Georgoulias V, Velidaki A, Archimandritis S, Karkavitsas NN (2000b) High intratumoral accumulation of stealth\u00ae liposomal doxorubicin (Caelyx\u00ae) in locally advanced sarcomas provides strong rational for combination with radiotherapy. Acta Oncologica 39: 207\u2013211","journal-title":"Acta Oncologica"},{"key":"BF6600486_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF02796209","volume":"17","author":"MI Koukourakis","year":"2001","unstructured":"Koukourakis MI, Giatromanolaki A, Kakolyris S, Froudarakis M, Georgoulias V, Retalis G, Bahlitzanakis N (2001) A phase I\/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF, in patients with incomplete response following docetaxel chemo-radiotherapy. Additional chemotherapy enhances regression of residual cancer. Med Oncol 17: 135\u2013143","journal-title":"Med Oncol"},{"key":"BF6600486_CR25","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/1097-0142(20000915)89:6<1380::AID-CNCR23>3.0.CO;2-R","volume":"89","author":"A Kotsakis","year":"2000","unstructured":"Kotsakis A, Sarra E, Peraki M, Koukourakis MI, Apostolaki S, Souglakos J, Mavromanomakis E, Vlachonicolis J, Georgoulias V (2000) Docetaxel-induced lymphopenia in patients with solid tumors. A prospective phenotypic analysis. Cancer 89: 1380\u20131386","journal-title":"Cancer"},{"key":"BF6600486_CR26","unstructured":"Lyass O, Lotem M, Edelmann D, Hubert A, Gabizon A (2001) Protective effect of amifostine (AMF) on doxil\/caelyx-induced palmar-plantar erythrodysesthesia (PPE) in patients with advanced cancer. Proc Am Soc Clin Oncol 20: abstract 2148"},{"key":"BF6600486_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/1097-0142(19950815)76:4<593::AID-CNCR2820760409>3.0.CO;2-N","volume":"76","author":"P Marino","year":"1995","unstructured":"Marino P, Preatoni A, Cantoni A (1995) Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis. Cancer 76: 593\u2013601","journal-title":"Cancer"},{"key":"BF6600486_CR28","first-page":"107","volume":"59","author":"L Milas","year":"1999","unstructured":"Milas L, Fujii T, Hunter N, Elshaikh M, Mason K, Plunkett W, Ang KK, Hittelman W (1999) Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res 59: 107\u2013114","journal-title":"Cancer Res"},{"key":"BF6600486_CR29","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1200\/JCO.1996.14.4.1071","volume":"14","author":"B Reckzeh","year":"1996","unstructured":"Reckzeh B, Merte H, Pfluger K, Pfab R, Wolf M, Havemann K (1996) Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small cell lung cancer. J Clin Oncol 14: 1071\u20131076","journal-title":"J Clin Oncol"},{"key":"BF6600486_CR30","doi-asserted-by":"crossref","unstructured":"RTOG late effects working group (1995) LENT SOMA tables. Radiother Oncol 35: 17\u201360","DOI":"10.1016\/0167-8140(95)90055-1"},{"key":"BF6600486_CR31","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/bjc.1996.276","volume":"3","author":"MI Saunders","year":"1996","unstructured":"Saunders MI, Dische S, Barret A, Parmar MK, Harvey A, Gibson D (1996) Randomized multicenter trials of CHART vs conventional radiotherapy in head-neck and non-small cell lung cancer. An interim report. Br J Cancer 3: 1455\u20131462","journal-title":"Br J Cancer"},{"key":"BF6600486_CR32","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1056\/NEJM199202203260805","volume":"326","author":"C Schaake-Koning","year":"1992","unstructured":"Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326: 524\u2013530","journal-title":"N Engl J Med"},{"key":"BF6600486_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/(SICI)1096-911X(200004)34:4<309::AID-MPO25>3.0.CO;2-X","volume":"34","author":"PJ Shaw","year":"2000","unstructured":"Shaw PJ, Bleakley M (2000) Systemic inflammatory response syndrome associated with amifostine. Med Pediatr Oncol 34: 309\u2013310","journal-title":"Med Pediatr Oncol"},{"issue":"Suppl 11","key":"BF6600486_CR34","first-page":"33","volume":"10","author":"S Stewart","year":"1997","unstructured":"Stewart S, Harrington KJ (1997) The biodistribution and pharmacokinetics of stealth liposomes in patients with solid tumors. Oncology 10: Suppl 11 33\u201337","journal-title":"Oncology"},{"key":"BF6600486_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1349-7006.1997.tb00369.x","volume":"88","author":"K Tamura","year":"1997","unstructured":"Tamura K, Takada M, Kawase I, Tada T, Kudoh S, Okishio K, Fukuoka M, Yamaoka N, Fujiwara Y, Yamakido M (1997) Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts. Jpn J Cancer Res 88: 218\u2013223","journal-title":"Jpn J Cancer Res"},{"key":"BF6600486_CR36","first-page":"804","volume":"20","author":"L Trodella","year":"2002","unstructured":"Trodella L, Granone P, Valente S, Turriziani A, Macis G, Corbo GM, Margaritora S, Cesario A, D'Angelillo RM, Gualano G, Ramella S, Galetta D, Cellini N (2002) Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer. J Clin Oncol 20: 804\u2013810","journal-title":"J Clin Oncol"},{"key":"BF6600486_CR37","unstructured":"World Health Organization (1979) Handbook for reporting results of cancer treatment. Geneva: WHO Offset Publ"},{"key":"BF6600486_CR38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nm0196-72","volume":"2","author":"AF Walf","year":"1996","unstructured":"Walf AF, Donaldson KL, Fairchild C, Lee FY, Foster SA, Demers GW, Galloway DA (1996) Loss of normal p53 function confers sensitization to Taxol by increasing G2\/M arrest and apoptosis. Nat Med 2: 72\u201379","journal-title":"Nat Med"},{"key":"BF6600486_CR39","first-page":"3352","volume":"54","author":"F Yuan","year":"1994","unstructured":"Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK (1994) Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in human tumor xenografts. Cancer Res 54: 3352\u20133356","journal-title":"Cancer Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6600486.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600486","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600486.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:44:16Z","timestamp":1684413856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6600486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["BF6600486"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6600486","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}